Year-End Report
THE LOEFFLER GROUP for INTROGEN THERAPEUTICS INC
Firm
Client
Income
$160,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Generic biologics
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM L BALL | N/A |
| KRISTEN P GULLOTT | — |
| WALLACE HENDERSON | — |
| MARCUS A KRAKER | N/A |
| THOMAS G LOEFFLER | N/A |
| JOSE E MARTINEZ | N/A |
| SUSAN NELSON | — |
| HANS C RICKHOFF | N/A |
| TIMOTHY N TUGGEY | — |
Medical/Disease Research/Clinical Labs MED
Generic biologics, intellectual property issues, food and drug administration issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM L BALL | N/A |
| KRISTEN P GULLOTT | — |
| WALLACE HENDERSON | — |
| MARCUS A KRAKER | N/A |
| THOMAS G LOEFFLER | N/A |
| JOSE E MARTINEZ | N/A |
| SUSAN NELSON | — |
| HANS C RICKHOFF | N/A |
| TIMOTHY N TUGGEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.